Even as the Philippines directed its collective attention toward the pandemic, a quieter epidemic continued its toll: stroke, the country's third leading cause of death, claimed nearly 100,000 Filipino lives in 2020 alone. In September 2021, Menarini Asia-Pac convened medical experts and a stroke survivor to illuminate how atrial fibrillation silently manufactures the blood clots that travel to the brain—and how that journey, so often fatal, is preventable. The campaign is a reminder that the oldest threats to human life do not pause for newer ones, and that prevention is less a medical miracl
Blood clots pose hidden threat as NCDs deprioritized during pandemic
Related Coverage
The New York Times examines why societies repeatedly direct hostility toward healthcare workers during epidemic outbreak…
News-Medical · Jul 21 Study finds no link between sleep chronotype and liver disease markersItalian researchers found no significant association between chronotype and liver fat or fibrosis in 119 adults with obe…
DD India · Jul 21 India Approves First Dengue Vaccine Qdenga for Ages 4-60India's drug regulator CDSCO has approved Qdenga, the country's first dengue vaccine, for ages 4-60. The Takeda-develope…
insightnews.com.au · Jul 21 Optical Dispenser's 28-Year Journey: Why Being Yourself Is Your SuperpowerSonya Broadhead, a 28-year optical industry veteran and co-owner of See Side Optical, reflects on her career evolution f…
Geopolitical Impact
This article is a health awareness campaign, not geopolitical news. It lacks international relations, power dynamics, or cross-border implications relevant to geopolitical analysis.
Bias & Framing
Article promotes pharmaceutical company's awareness campaign on blood clots with minimal critical perspective on corporate messaging or potential conflicts of interest.
Sponsored content framing disguised as health journalism; uses public health crisis (COVID deprioritization of NCDs) as narrative hook to legitimize corporate campaign without disclosing commercial interests or examining industry motivations.
Economic Lens
Pharmaceutical awareness campaign highlights thrombosis risks amid NCD deprioritization during pandemic, signaling potential market opportunity for anticoagulant medications and preventive healthcare services in Philippines.
Increased medication adherence and preventive care awareness may reduce out-of-pocket emergency healthcare costs for Filipino households, though chronic medication expenses could rise. Stroke prevention through anticoagulant therapy represents significant long-term healthcare spending.
Government may need to rebalance healthcare priorities toward NCDs despite pandemic focus, potentially increasing pharmaceutical subsidies for anticoagulants, strengthening stroke prevention programs, and integrating thrombosis screening into primary care protocols. Insurance coverage expansion for preventive medications may be warranted.